Frontiers in neuroscience · 2026
Analytical validation of digital measure of intelligibility in progressive supranuclear palsy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yıldız Potter İlkay, Mishra Ram Kinker, Pawar Tejas, Wang Jesse, Mefferd Antje S, de Riesthal Michael, Kuruvilla-Dugdale Mili, Wills Anne-Marie, Pantelyat Alexander, Vaziri Ashkan
Аннотация
INTRODUCTION: Progressive supranuclear palsy (PSP) causes progressive speech impairment. Digital speech analysis can objectively and remotely quantify measures like intelligibility, typically judged subjectively by experts during clinical visits. The objective of this study is to validate digital intelligibility measurement in PSP via BioDigit Speech (BioSensics LLC, United States).
METHODS: Forty-nine PSP patients performed standardized passage-reading scored by BioDigit Speech and three experts (18 + years of experience); expert mean score (EMS) served as the reference standard.
RESULTS: Digital intelligibility showed high correlation and agreement with EMS (r = 0.90, ICC = 0.84 in native speakers), while systematically scoring below EMS. Moreover, the digital measure discriminated PSP clinical severity as well as or better than EMS, particularly for PSP-QoL-11 with a steeper standardized response. Correlations of digital measure with the clinical scales were moderate (up to -0.51), significant (p-values <0.02) and consistently higher than the ones of EMS. Raters appeared to use top-down information to recover underlying messages, resulting in saturated scores near 1.0 and low-to-moderate inter-rater agreement.
CONCLUSION: Collected remotely with minimal burden, digital speech measures like intelligibility may serve as objective, sensitive outcomes for communication-focused interventions and PSP trials.
METHODS: Forty-nine PSP patients performed standardized passage-reading scored by BioDigit Speech and three experts (18 + years of experience); expert mean score (EMS) served as the reference standard.
RESULTS: Digital intelligibility showed high correlation and agreement with EMS (r = 0.90, ICC = 0.84 in native speakers), while systematically scoring below EMS. Moreover, the digital measure discriminated PSP clinical severity as well as or better than EMS, particularly for PSP-QoL-11 with a steeper standardized response. Correlations of digital measure with the clinical scales were moderate (up to -0.51), significant (p-values <0.02) and consistently higher than the ones of EMS. Raters appeared to use top-down information to recover underlying messages, resulting in saturated scores near 1.0 and low-to-moderate inter-rater agreement.
CONCLUSION: Collected remotely with minimal burden, digital speech measures like intelligibility may serve as objective, sensitive outcomes for communication-focused interventions and PSP trials.